Phil Hart, MD, is a physician–scientist who is an endowed Professor of Medicine at The Ohio State University Wexner MedicalCenter with expertise in the design and conduct of clinical research and trials. He has over a decade of experience designingand leading a range of studies, including large, multicenter clinical trials and prospective cohort studies.
Dr. Hart’s academic niche relates to diseases of the exocrine pancreas, including acute and chronic pancreatitis, early detection of pancreatic cancer, and IgG4-related disease. He was PI of the TACTIC study (the largest multinational RCT in chronic pancreatitis), and has co-chaired an NIH workshop on the Design and Conduct of Clinical Trials in Pancreatitis. While the primary source of funding for his work is federal, he also has experience with industry sponsored research, including serving on advisory boards for multiple phase 3 RCTs.
Dr. Hart has extensive experience in protocol development, endpoint selection, and data safety monitoring. He collaborates closely with biostatisticians, translational scientists, and clinical research teams to ensure rigorous study design and high-quality data capture. His leadership in multisite studies includes standardization of procedures, centralized data coordination and harmonization of bio specimen collection, enabling scalable and reproducible research across institutions. He will used these experiences and perspectives to serve as Medical Director for the Multisite Trials Coordinating Center (MTCC) where he will work directly with clinician scientists to provide support throughout the project lifespan, including protocol development, multisite trial coordination, data analysis and dissemination.